Resistance Mutations after Sotrovimab Use Among the first 100 patients who received
sotrovimab, a monoclonal antibody directed against SARS-CoV-2, at a center in Australia, 8 had …

The SARS-CoV-2 epidemic has rapidly spread outside China with major outbreaks occurring
in Italy, South Korea, and Iran. Phylogenetic analyses of whole-genome sequencing data …

Considerable concerns relating to the duration of protective immunity against severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) exist, with evidence of antibody titers …

Understanding the long-term maintenance of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) immunity is critical for predicting protection against reinfection. In an age- …

To date, 18 living recommendations for the clinical care of pregnant and postpartum women
with COVID‐19 have been issued by the National COVID‐19 Clinical Evidence Taskforce. …

Angioinvasive complications of Scedosporium infections are rare. We report two cases of
mycotic aneurysm, following apparent localized infection, due to Scedosporium apiospermum …

Background Diabetes has been recognised as a major risk factor for COVID‐19 mortality
and hospital complications in earlier studies. Aims To examine the characteristics of …

Health care workers’ (HCWs) lived experiences and perceptions of the pandemic can prove
to be a valuable resource in the face of a seemingly persistent Novel coronavirus disease …

Several Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) neutralising
monoclonal antibodies (mAbs) have received emergency use authorisation by regulatory …

Phagocytic responses by effector cells to opsonized viruses have been recognized to play a
key role in antiviral immunity. Limited data on coronavirus disease 2019 suggest that the …